首页> 美国卫生研究院文献>other >Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohns Disease in a Chinese Family Study
【2h】

Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohns Disease in a Chinese Family Study

机译:外显子组测序在中国家庭研究中确定DLG1为克罗恩病的潜在易感性新基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundGenetic variants make some contributions to inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). More than 100 susceptibility loci were identified in Western IBD studies, but susceptibility gene has not been found in Chinese IBD patients till now. Sequencing of individuals with an IBD family history is a powerful approach toward our understanding of the genetics and pathogenesis of IBD. The aim of this study, which focuses on a Han Chinese CD family, is to identify high-risk variants and potentially novel loci using whole exome sequencing technique.
机译:背景技术遗传变异对炎症性肠病(IBD)有所贡献,包括克罗恩病(CD)和溃疡性结肠炎(UC)。在西方IBD研究中鉴定出了100多个易感基因座,但到目前为止,在中国IBD患者中还没有发现易感基因。对具有IBD家族史的个体进行测序是一种强有力的方法,可帮助我们了解IBD的遗传学和发病机理。这项研究的重点是汉族CD族,目的是使用整体外显子组测序技术鉴定高风险变异体和潜在的新型基因座。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号